{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:21:24Z","timestamp":1784920884939,"version":"3.55.0"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00247","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:54:31Z","timestamp":1593546871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Stabilization Beyond Mood: Stabilizing Patients With Bipolar Disorder in the Various Phases of Life"],"prefix":"10.3389","volume":"11","author":[{"given":"Alessio","family":"Simonetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia E.","family":"Koukopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios D.","family":"Kotzalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfina","family":"Janiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"De Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Janiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb01331.x","article-title":"Factors associated with discontinuation of long-term lithium treatment","volume":"80","author":"Nilsson","year":"1989","journal-title":"Acta Psychiatr Scand"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-1781(99)00108-0","article-title":"Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients","volume":"89","author":"Schumann","year":"1999","journal-title":"Psychiatry Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0165-0327(96)00018-3","article-title":"Late non-response to lithium prophylaxis in bipolar patients: prevalence and predictors","volume":"39","author":"Maj","year":"1996","journal-title":"J Affect Disord"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.10.031","article-title":"Age at onset of bipolar disorder in a Norwegian catchment area sample","volume":"124","author":"Larsson","year":"2010","journal-title":"J Affect Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jad.2016.04.006","article-title":"Admixture analysis of age at onset in first episode bipolar disorder","volume":"201","author":"Nowrouzi","year":"2016","journal-title":"J Affect Disord"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.02.001","article-title":"The neurocognitive signature of psychotic bipolar disorder","volume":"62","author":"Glahn","year":"2007","journal-title":"Biol Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2011.02.011","article-title":"Toward a functional neuroanatomical signature of bipolar disorder: quantitative evidence from the neuroimaging literature","volume":"193","author":"Kupferschmidt","year":"2011","journal-title":"Psychiatry Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160708231216","article-title":"Neurobiological Evidence for the Primacy of Mania Hypothesis","volume":"15","author":"Kotzalidis","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jad.2019.04.071","article-title":"Hippocampal subfield volumes and childhood trauma in bipolar disorders","volume":"253","author":"Janiri","year":"2019","journal-title":"J Affect Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/archpsyc.65.4.395","article-title":"A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes","volume":"65","author":"Padmos","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0531-2","article-title":"Treatment of bipolar disorder in a lifetime perspective: is lithium still the best choice","volume":"37","author":"Sani","year":"2017","journal-title":"Clin Drug Investig"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(89)90034-4","article-title":"Long-term effects of lithium on the kidney: functional-morphological correlations","volume":"23","author":"Hetmar","year":"1989","journal-title":"J Psychiatr Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/9.9.1250","article-title":"Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium","volume":"9","author":"Bendz","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40345-017-0096-2","article-title":"Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters","volume":"5","author":"Tondo","year":"2017","journal-title":"Int J Bipolar Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-0404.1983.tb01536.x","article-title":"Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy","volume":"68","author":"Ker\u00e4nen","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"B16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/YIC.0000000000000260","article-title":"Personalized and precision medicine as informants for treatment management of bipolar disorder","volume":"34","author":"Perugi","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2001.030304.x","article-title":"On defining \u2018mood stabilizer'","volume":"3","author":"Ghaemi","year":"2001","journal-title":"Bipolar Disord"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12579","article-title":"Definition of the term \u201cmood stabilizer","volume":"20","author":"Ketter","year":"2018","journal-title":"Bipolar Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-642-70140-5_5","article-title":"Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivity","author":"Scatton","year":"1985","journal-title":"Psychopharmacology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/10799893.2015.1072976","article-title":"Selective disruption of dopamine D2-receptors\/beta-arrestin2 signaling by mood stabilizers","volume":"35","author":"Del' Guidice","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.220","article-title":"The aversive agent lithium chloride suppresses phasic dopamine release through central GLP-1 receptors","volume":"41","author":"Fortin","year":"2016","journal-title":"Neuropsychopharmacology."},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-020-01096-0","article-title":"ACC Glu\/GABA ratio is decreased in euthymic bipolar disorder I patients: possible in vivo neurometabolite explanation for mood stabilization","volume-title":"Eur Arch Psychiatry Clin Neurosci","author":"Scotti-Muzzi","year":"2020"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00918","article-title":"Emerging adulthood, a pre-adult life-history stage","volume":"10","author":"Hochberg","year":"2020","journal-title":"Front Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316909110","article-title":"Sex differences in the structural connectome of the human brain","volume":"111","author":"Ingalhalikar","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12663","article-title":"Sex differences in brain structure among adolescents with bipolar disorder","volume-title":"Bipolar Disord","author":"Mitchell","year":"2018"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160607101400","article-title":"Who's the leader, mania or depression? Predominant polarity and alcohol\/polysubstance use in bipolar disorders","volume":"15","author":"Janiri","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-017-0782-1","article-title":"Relationship of bipolar disorder with psychiatric comorbidity in the postpartum period-a scoping review","volume":"21","author":"Sharma","year":"2018","journal-title":"Arch Womens Ment Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.08.042","article-title":"Is parity status associated with bipolar disorder clinical features, severity or evolution","volume":"225","author":"Tebeka","year":"2018","journal-title":"J Affect Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223\/83\/0900-1093","article-title":"Does lithium stabilize mood","volume":"18","author":"DePaulo","year":"1983","journal-title":"Biol Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0402","article-title":"Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients","volume":"59","author":"Goldberg","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1176\/ps.49.9.1145","article-title":"Use of mood stabilizers by hospitalized geriatric patients with bipolar disorder","volume":"49","author":"Sanderson","year":"1998","journal-title":"Psychiatr Serv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1023\/a:1022361412956","article-title":"Gabapentin as an adjunct to standard mood stabilizers in out patients with mixed bipolar symptomatology","volume":"11","author":"Sokolski","year":"1999","journal-title":"Ann Clin Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.157.1.124","article-title":"Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression","volume":"157","author":"Young","year":"2000","journal-title":"Am J Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/070674370104600925","article-title":"Treatment of mixed mania with risperidone and mood stabilizers","volume":"46","author":"Benabarre","year":"2001","journal-title":"Can J Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0165-0327(00)00172-5","article-title":"Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients","volume":"63","author":"Bottlender","year":"2001","journal-title":"J Affect Disord"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v62n1204","article-title":"Effective mood stabilization with a chelated mineral supplement: an open-label trial in bipolar disorder","volume":"62","author":"Kaplan","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v62n1210","article-title":"Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania","volume":"62","author":"Miller","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2001.30505.x","article-title":"Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers","volume":"3","author":"Post","year":"2001","journal-title":"Bipolar Disord"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(01)00434-7","article-title":"Divalproex therapy in medication-na\u00efve and mood-stabilizer-na\u00efve bipolar II depression","volume":"67","author":"Winsberg","year":"2001","journal-title":"J Affect Disord"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.40103.x","article-title":"The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania","volume":"4","author":"Baker","year":"2002","journal-title":"Bipolar Disord"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01189.x","article-title":"Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study","volume":"4","author":"McIntyre","year":"2002","journal-title":"Bipolar Disord"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v63n0607","article-title":"A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers","volume":"63","author":"Vieta","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0316","article-title":"Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer","volume":"64","author":"Henry","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial","volume":"182","author":"Yatham","year":"2003","journal-title":"Br J Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v65n0518","article-title":"Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder","volume":"65","author":"Bowden","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.564","article-title":"Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression","volume":"161","author":"Goldberg","year":"2004","journal-title":"Am J Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0506","article-title":"Anger attacks in bipolar depression: predictors and response to citalopram added to mood stabilizers","volume":"65","author":"Mammen","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br J Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.yic.0000138821.85744.20","article-title":"Risperidone in combination with mood stabilizers for acute mania: a multicentre, open study","volume":"19","author":"Bahk","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hup.577","article-title":"Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study","volume":"19","author":"Bahk","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.01.006","article-title":"Mood stabilizer augmentation in apparently \u201cunipolar\u201d MDD: predictors of response in the naturalistic French national EPIDEP study","volume":"84","author":"Hantouche","year":"2005","journal-title":"J Affect Disord"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/bf02384203","article-title":"Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic","volume":"32","author":"Patel","year":"2005","journal-title":"J Behav Health Serv Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v67n1105","article-title":"Clinical Affairs Product Support Study-168 Investigators. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial","volume":"67","author":"Chengappa","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers","volume":"163","author":"Leverich","year":"2006","journal-title":"Am J Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.01.024","article-title":"SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study","volume":"92","author":"Parker","year":"2006","journal-title":"J Affect Disord"},{"key":"B59","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1017\/s1092852900014802","article-title":"Adjunctive treatment for mood stabilization of patients with bipolar I disorder treated with lamotrigine","volume":"11","author":"Spaulding","year":"2006","journal-title":"CNS Spectr"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.03.007","article-title":"Atypical antipsychotics as \u201cmood stabilizers\u201d: a retrospective chart review","volume":"31","author":"Savas","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0024","article-title":"Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial","volume":"17","author":"Tramontina","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.01.017","article-title":"Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study","volume":"110","author":"Altamura","year":"2008","journal-title":"J Affect Disord"},{"key":"B64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2147\/NDT.S5970","article-title":"Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset","volume":"5","author":"Dell'Osso","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04381","article-title":"Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo","volume":"70","author":"Goldberg","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.07.020","article-title":"Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers","volume":"34","author":"Chang","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1096","article-title":"Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study","volume":"25","author":"Quante","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05570gre","article-title":"Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial","volume":"72","author":"Muzina","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.666961","article-title":"Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic\/mixed episodes for Japanese patients with bipolar I disorder","volume":"28","author":"Katagiri","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.09.040","article-title":"The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial","volume":"136","author":"Koukopoulos","year":"2012","journal-title":"J Affect Disord"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.04.037","article-title":"A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression","volume":"144","author":"Goldberg","year":"2013","journal-title":"J Affect Disord"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.06.023","article-title":"A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder","volume":"144","author":"Norris","year":"2013","journal-title":"J Affect Disord"},{"key":"B73","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pds.3568","article-title":"Comparative effectiveness of monotherapy with mood stabilizers versus second generation (atypical) antipsychotics for the treatment of bipolar disorder in children and adolescents","volume":"23","author":"Chen","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000160","article-title":"Outcome of mood stabilizer discontinuation in bipolar disorder after 5 years of euthymia","volume":"34","author":"Sharma","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13111501","article-title":"The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer","volume":"171","author":"Viktorin","year":"2014","journal-title":"Am J Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.05.070","article-title":"Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study","volume":"185","author":"Amsterdam","year":"2015","journal-title":"J Affect Disord"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12459","article-title":"Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study","volume":"18","author":"Hochman","year":"2016","journal-title":"Bipolar Disord"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2016.02.064","article-title":"Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale","volume":"197","author":"Shansis","year":"2016","journal-title":"J Affect Disord"},{"key":"B80","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1192\/bjp.bp.114.147587","article-title":"Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial","volume":"208","author":"Yatham","year":"2016","journal-title":"Br J Psychiatry"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.158","article-title":"Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial","volume":"21","author":"Yatham","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40345-017-0093-5","article-title":"Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study","volume":"5","author":"Ahn","year":"2017","journal-title":"Int J Bipolar Disord"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.08.429","article-title":"Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial","volume":"27","author":"Garriga","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000211","article-title":"Outcome and predictors of remission in bipolar-I patients experiencing manic episode and treated with oral antipsychotics and\/or mood stabilizers: a prospective observational study in Italy","volume":"33","author":"Perugi","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40345-019-0154-z","article-title":"Trajectories of adherence to mood stabilizers in patients with bipolar disorder","volume":"7","author":"Bauer","year":"2019","journal-title":"Int J Bipolar Disord"},{"key":"B86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2019.06.013","article-title":"Lithium versus other mood stabilizing medications in a longitudinal study of bipolar youth","volume-title":"J Am Acad Child Adolesc Psychiatry","author":"Hafeman","year":"2019"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.10.360","article-title":"Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments","volume":"245","author":"Steardo","year":"2019","journal-title":"J Affect Disord"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.07.054","article-title":"Conventional mood stabilizers and\/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure","volume":"257","author":"Tournier","year":"2019","journal-title":"J Affect Disord"},{"key":"B89","article-title":"Bipolar disorders and bipolarity: the notion of the \u201cmixity","volume":"31","author":"Tavormina","year":"2019","journal-title":"Psychiatr Danub"},{"key":"B90","first-page":"9","article-title":"An approach to treat bipolar disorders mixed states","volume":"28","author":"Tavormina","year":"2016","journal-title":"Psychiatr Danub"},{"key":"B91","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpsychires.2017.07.013","article-title":"FACE-BD Clinical Coordinating Center (FondaMental Foundation); FACE-BD Data Coordinating Center (FondaMental Foundation); FACE-BD Clinical Sites and Principal Collaborators in France. Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: A pathway analysis","volume":"95","author":"Etain","year":"2017","journal-title":"J Psychiatr Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0b013e3182218c8c","article-title":"Successful and rapid response to electroconvulsive therapy of a suicidal patient with comorbid bipolar I disorder and histrionic personality disorder","volume":"28","author":"Rapinesi","year":"2012","journal-title":"J ECT"},{"key":"B94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2016.06.049","article-title":"Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex reduces cocaine craving in patients with cocaine use disorder","volume":"629","author":"Rapinesi","year":"2016","journal-title":"Neurosci Lett"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/13554794.2012.690429","article-title":"Deep transcranial magnetic stimulation for treatment-resistant bipolar depression: a case report of acute and maintenance efficacy","volume":"19","author":"Bersani","year":"2013","journal-title":"Neurocase"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:54:37Z","timestamp":1593546877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":94,"alternative-id":["10.3389\/fpsyt.2020.00247"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00247","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"article-number":"247"}}